Concepedia

Ali M. Janabi

AM

Statistics

Publications

5

Citations

63

H-Index

5

Active since

2022

Affiliations

University of Kufa(Current)

University of Alkafeel

Ali M. Janabi is an author at University of Kufa specializing in reduced cardiovascular toxicity, doxorubicin cardiotoxicity, and cardiotoxicity.

ORCID

Publications per year

2022–2024

5

Publications

5

Nephroprotective role of resveratrol in renal ischemia-reperfusion injury: a preclinical study in Sprague-Dawley rats

Elaf R. Alaasam, Ali M. Janabi, Karrar M. Al-Buthabhak et al. · BMC Pharmacology and Toxicology · 2024 · 18 citations · Full text

, , +16

Dipyridamole ameliorates doxorubicin-induced cardiotoxicity

Esraa A. Alyasiry, Ali M. Janabi, Najah R. Hadi · Journal of Medicine and Life · 2022 · 15 citations · Full text

, , +15

Ameliorative effect of nebivolol in doxorubicin-induced cardiotoxicity

Najah Rayish Hadi, Hussein Al-Amir, Ali M. Janabi · Journal of Medicine and Life · 2023 · 10 citations · Full text

, , +17

Moexipril Improves Renal Ischemia/Reperfusion Injury in Adult Male Rats

Esraa H. Alsaaty, Ali M. Janabi · Journal of Contemporary Medical Sciences · 2024 · 10 citations · Full text

, , +16

Azilsartan improves doxorubicin-induced cardiotoxicity via inhibiting oxidative stress, proinflammatory pathway, and apoptosis

Ali M. Janabi, Mohammed Al-Chlaihawi · Journal of Medicine and Life · 2023 · 10 citations · Full text

, , +17

1–5 of 5